Literature DB >> 4001992

Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response.

L Temoshok.   

Abstract

A series of seven studies investigating biopsychosocial aspects of cutaneous malignant melanoma were conducted by a multidisciplinary group of researchers at the University of California, San Francisco. Two studies investigated the relationship of variables derived from a videotaped psychosocial interview and from self-report measures, and two histopathologic indicators: tumor thickness and level of invasion. Associations of psychosocial variables to prognostic indicators were stronger within the younger vs the older subject group. In a multiple regression analysis, patient delay in seeking medical attention emerged as the most significant variable predicting tumor thickness. A study of factors related to patient delay found longer delays in patients who had lesions on the back, less previous knowledge of melanoma, less understanding of its treatment and less minimization of its seriousness. Another study compared the repressive coping reactions--defined as the discrepancy between reported anxiety and that reflected in electrodermal activity--in melanoma patients, cardiovascular disease patients and disease-free controls. The melanoma group was significantly more 'repressed' on the combined self-report/physiological measure, as well as on other self-report measures of repressiveness. In order to investigate the relationship of psychosocial factors to more disease-relevant physiological variables, the next study focused on two clinical variables significantly predictive of disease outcome:mitotic rate of the tumor and lymphocytes at tumor site. Emotional expression of sadness and anger, rated from the videotaped interviews, was positively correlated with tumor-specific host-response factors and negatively correlated with mitotic rate. In another study, subjects who had died or had disease progression were matched on the basis of tumor and demographic characteristics with subjects who had no evidence of disease by follow-up. The unfavorable outcome group had higher scores on self-report scales of dysophoric emotion and distress which were administered one to three years previously. An experimental investigation of relationships among behavioral, physiological and tumor outcome variables in the Syrian hamster found that general activity was correlated positively with greater tumor growth following induction. These results were compared to those from the preceeding two human studies, and discussed in terms of a stress-arousal-coping model.

Entities:  

Mesh:

Year:  1985        PMID: 4001992     DOI: 10.1016/0277-9536(85)90338-7

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  10 in total

1.  Anxiety in patients with symptomatic breast disease: effects of immediate versus delayed communication of results.

Authors:  S S Ubhi; P Shaw; S Wright; A Stotter; L Clarke; R Windle; S Black
Journal:  Ann R Coll Surg Engl       Date:  1996-09       Impact factor: 1.891

Review 2.  What is the state of the evidence on the mind-cancer survival question, and where do we go from here? A point of view.

Authors:  Joanne E Stephen; Michelle Rahn; Marja Verhoef; Anne Leis
Journal:  Support Care Cancer       Date:  2007-06-26       Impact factor: 3.603

3.  Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores.

Authors:  N Mackworth; P Fobair; M D Prados
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

4.  Which symptoms matter? Self-report and observer discrepancies in repressors and high-anxious women with metastatic breast cancer.

Authors:  Janine Giese-Davis; Rie Tamagawa; Maya Yutsis; Suzanne Twirbutt; Karen Piemme; Eric Neri; C Barr Taylor; David Spiegel
Journal:  J Behav Med       Date:  2012-10-20

5.  High-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma.

Authors:  Firdaus S Dhabhar; Alison N Saul; Tyson H Holmes; Christine Daugherty; Eric Neri; Jean M Tillie; Donna Kusewitt; Tatiana M Oberyszyn
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

6.  Chinese medicine and biomodulation in cancer patients--Part one.

Authors:  S M Sagar; R K Wong
Journal:  Curr Oncol       Date:  2008-01       Impact factor: 3.677

Review 7.  HIV and psychoimmunology: evidence promising and forthcoming.

Authors:  D Miller; K H Nott; K Vedhara
Journal:  J R Soc Med       Date:  1994-11       Impact factor: 18.000

8.  Exploring Knowledge, Attitudes, and Practice Associated With Meditation Among Patients With Melanoma.

Authors:  Lahiru Russell; Liliana Orellana; Anna Ugalde; Donna Milne; Meinir Krishnasamy; Richard Chambers; Patricia M Livingston
Journal:  Integr Cancer Ther       Date:  2017-03-24       Impact factor: 3.279

9.  Health effects of expressive writing on stressful or traumatic experiences - a meta-analysis.

Authors:  Carolin Mogk; Sebastian Otte; Bettina Reinhold-Hurley; Birgit Kröner-Herwig
Journal:  Psychosoc Med       Date:  2006-11-16

Review 10.  Neuroendocrine Factors in Melanoma Pathogenesis.

Authors:  Cristian Scheau; Carmen Draghici; Mihaela Adriana Ilie; Mihai Lupu; Iulia Solomon; Mircea Tampa; Simona Roxana Georgescu; Ana Caruntu; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.